244 related articles for article (PubMed ID: 35378684)
1. The Role of the Complement System in Chronic Inflammatory Demyelinating Polyneuropathy: Implications for Complement-Targeted Therapies.
Querol LA; Hartung HP; Lewis RA; van Doorn PA; Hammond TR; Atassi N; Alonso-Alonso M; Dalakas MC
Neurotherapeutics; 2022 Apr; 19(3):864-873. PubMed ID: 35378684
[TBL] [Abstract][Full Text] [Related]
2. Antibody- and macrophage-mediated segmental demyelination in chronic inflammatory demyelinating polyneuropathy: clinical, electrophysiological, immunological and pathological correlates.
Vallat JM; Mathis S; Vegezzi E; Richard L; Duchesne M; Gallouedec G; Corcia P; Magy L; Uncini A; Devaux J
Eur J Neurol; 2020 Apr; 27(4):692-701. PubMed ID: 31769579
[TBL] [Abstract][Full Text] [Related]
3. Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP.
Sommer C; Koch S; Lammens M; Gabreels-Festen A; Stoll G; Toyka KV
Neurology; 2005 Dec; 65(12):1924-9. PubMed ID: 16380614
[TBL] [Abstract][Full Text] [Related]
4. Fibronectin connecting segment-1 peptide inhibits pathogenic leukocyte trafficking and inflammatory demyelination in experimental models of chronic inflammatory demyelinating polyradiculoneuropathy.
Dong C; Greathouse KM; Beacham RL; Palladino SP; Helton ES; Ubogu EE
Exp Neurol; 2017 Jun; 292():35-45. PubMed ID: 28215575
[TBL] [Abstract][Full Text] [Related]
5. Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go.
Nobile-Orazio E
J Peripher Nerv Syst; 2014 Mar; 19(1):2-13. PubMed ID: 24612201
[TBL] [Abstract][Full Text] [Related]
6. Different patterns of sensory nerve involvement in chronic inflammatory demyelinating polyneuropathy subtypes.
Shibuya K; Tsuneyama A; Misawa S; Suzuki YI; Suichi T; Kojima Y; Nakamura K; Kano H; Ohtani R; Aotsuka Y; Morooka M; Prado M; Kuwabara S
Muscle Nerve; 2022 Aug; 66(2):131-135. PubMed ID: 35307862
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of sural nerve demyelination in chronic inflammatory demyelinating polyneuropathy.
Bosboom WM; van den Berg LH; Franssen H; Giesbergen PC; Flach HZ; van Putten AM; Veldman H; Wokke JH
Brain; 2001 Dec; 124(Pt 12):2427-38. PubMed ID: 11701597
[TBL] [Abstract][Full Text] [Related]
8. [Chronic inflammatory demyelinating polyneuropathy].
Köller H; Kieseier BC; Jander S; Hartung HP
Nervenarzt; 2003 Apr; 74(4):320-33. PubMed ID: 12707701
[TBL] [Abstract][Full Text] [Related]
9. Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy.
Kuwabara S; Isose S; Mori M; Mitsuma S; Sawai S; Beppu M; Sekiguchi Y; Misawa S
J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1054-9. PubMed ID: 25424435
[TBL] [Abstract][Full Text] [Related]
10. Clinical management of chronic inflammatory demyelinating polyneuropathy (CIDP) in Europe and India: An exploratory study.
Svačina MKR; Mehndiratta MM; Vedeler CA; Sharma Y; Bobylev I; Sprenger A; Remke G; Wüstenberg H; Klein I; Joshi A; Lehmann HC
J Neurol Sci; 2021 Aug; 427():117507. PubMed ID: 34130060
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiological sensory demyelination in typical chronic inflammatory demyelinating polyneuropathy.
Rajabally YA; Samarasekera S
Eur J Neurol; 2010 Jul; 17(7):939-44. PubMed ID: 20158514
[TBL] [Abstract][Full Text] [Related]
12. [Recent topics of chronic inflammatory demyelinating polyneuropathy].
Iijima M
Rinsho Shinkeigaku; 2012; 52(11):917-9. PubMed ID: 23196467
[TBL] [Abstract][Full Text] [Related]
13. Chronic Inflammatory Demyelinating Polyneuropathy.
Kuwabara S; Misawa S
Adv Exp Med Biol; 2019; 1190():333-343. PubMed ID: 31760654
[TBL] [Abstract][Full Text] [Related]
14. Chronic inflammatory demyelinating polyneuropathy.
Said G
Neuromuscul Disord; 2006 May; 16(5):293-303. PubMed ID: 16631367
[TBL] [Abstract][Full Text] [Related]
15. [Chronic inflammatory demyelinating polyradiculoneuropathy: clinical heterogeneity and therapeutic perspectives].
Leger JM; Bombelli F; Tran-Thanh H; Chassande B; Maisonobe T; Viala K
Bull Acad Natl Med; 2010; 194(4-5):753-64; discussion 764-5. PubMed ID: 21568049
[TBL] [Abstract][Full Text] [Related]
16. The spectrum of chronic inflammatory demyelinating polyneuropathy.
Rotta FT; Sussman AT; Bradley WG; Ram Ayyar D; Sharma KR; Shebert RT
J Neurol Sci; 2000 Feb; 173(2):129-39. PubMed ID: 10675657
[TBL] [Abstract][Full Text] [Related]
17. [Immune-mediated neuropathies: indications and value of nerve biopsy].
Verschueren A
Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S58-60. PubMed ID: 18087231
[TBL] [Abstract][Full Text] [Related]
18. Ultrastructural mechanisms of macrophage-induced demyelination in CIDP.
Koike H; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G
Neurology; 2018 Dec; 91(23):1051-1060. PubMed ID: 30429275
[TBL] [Abstract][Full Text] [Related]
19. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): Current Therapies and Future Approaches.
Svačina MKR; Lehmann HC
Curr Pharm Des; 2022; 28(11):854-862. PubMed ID: 35339172
[TBL] [Abstract][Full Text] [Related]
20. History, Diagnosis, and Management of Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Dyck PJB; Tracy JA
Mayo Clin Proc; 2018 Jun; 93(6):777-793. PubMed ID: 29866282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
